BridgeMD
New treatment option for Breast Cancer Susceptibility Gene (BRCA1) Mutation
Official title Cognitive Behavioral Therapy for Fear of Cancer Recurrence in Women With BRCA1/2 Gene
ClinicalTrials.gov ID: NCT06817694
What this study is testing
- What it's testing
- The goal of this clinical trial is to determine whether an adapted version of a current cognitive-behavioural group therapy (CBT) protocol for cancer survivors to the specific needs of women who are carriers of the BRCA1/2 genetic mutation will reduce their levels of fear of cancer recurrence. The main questions this study aims to answer are: Will the women who have received the adapted CBT be satisfied with it?
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older, women only
You may be able to join if
- 1) Have completed primary treatment for breast or ovarian cancer (i.e., surgery, chemotherapy, and radiotherapy).
- 2) Be known to carry a BRCA1/2 pathogenic mutation.
- 3) Have a clinical level of fear of cancer recurrence as defined by a score of 13 or more on the Fear of Cancer Recurrence Inventory severity...
- 4) Be at least 18 years of age.
- 5) Be able to read, understand and express herself in French.
You likely can't join if
- 1) Have distant metastases (in the case of ovarian cancer, only stages IV and IIIC will be excluded).
- 2) Be known to carry a BRCA1/2 "VUS" mutation.
- 3) Have a known cognitive disorder.
- 4) Have a known severe psychological disorder (e.g., psychotic disorder, bipolar disorder, substance abuse or dependence disorder).
- 5) Have already taken part in the original FCR group psychotherapy at the CHU de Québec.
- 6) Women taking psychotropic medication are eligible, but only if the dosage has been stable for at least one month.
The study team makes the final eligibility decision.
Where it's taking place
- Québec, Quebec, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Québec, Quebec, Canada. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.